This topic contains a solution. Click here to go to the answer

Author Question: Which of the following measures of variability is not sensitive to extreme values? a. The range b. ... (Read 157 times)

mynx

  • Hero Member
  • *****
  • Posts: 555
Which of the following measures of variability is not sensitive to extreme values?
 a. The range
  b. The standard deviation
  c. The interquartile range
  d. The coefficient of variation

Question 2

Which measures of central location and variability are considered to be resistant to extreme values?
 a. The mean and standard deviation.
  b. The mode and variance.
  c. The median and interquartile range.
  d. None of these choices.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Jayson

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

C

Answer to Question 2

C




mynx

  • Member
  • Posts: 555
Reply 2 on: Jun 24, 2018
Great answer, keep it coming :)


essyface1

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library